CANF
Can Fite Biopharma Ltd ADR
NYSE MKT: CANF · HEALTHCARE · BIOTECHNOLOGY
$3.10
+3.68% today
Updated 2026-04-30
Market cap
$6.23M
P/E ratio
—
P/S ratio
15.39x
EPS (TTM)
$-10.75
Dividend yield
—
52W range
$3 – $24
Volume
1.4M
Can Fite Biopharma Ltd ADR (CANF) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.65M | $-5.50M | $-4.35M | $-8.63M | $-7.33M | $-4.65M | $-8.93M | $-9.52M | $-4.16M | $-10.83M | $-12.06M | $-9.86M | $-10.80M | $-8.44M | $-7.64M | $-9.02M |
| Capital expenditures | $30157.00 | $21282.00 | $4550.00 | $12347.00 | $9501.00 | $45342.00 | $10398.00 | $6905.00 | $33000.00 | $3000.00 | $26000.00 | $11000.00 | $9000.00 | $2000.00 | $5000.00 | $2018.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $177000.00 | $83815.00 | $389727.00 | $787939.00 | $211995.00 | $109000.00 | $309000.00 | $195074.00 | $535000.00 | $385000.00 | $355000.00 | $398000.00 | $263000.00 | $261000.00 | $362000.00 | $340000.00 |
| Free cash flow | $-3.68M | $-5.52M | $-4.35M | $-8.64M | $-7.34M | $-4.70M | $-8.94M | $-9.53M | $-4.19M | $-10.84M | $-12.09M | $-9.87M | $-10.81M | $-8.44M | $-7.64M | $-9.02M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $715000.00 | $2.59M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |